These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 355732

  • 1. Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.
    Fleming CR, Ludwig J, Dickson ER.
    Mayo Clin Proc; 1978 Sep; 53(9):587-93. PubMed ID: 355732
    [Abstract] [Full Text] [Related]

  • 2. Trial of penicillamine in advanced primary biliary cirrhosis.
    Dickson ER, Fleming TR, Wiesner RH, Baldus WP, Fleming CR, Ludwig J, McCall JT.
    N Engl J Med; 1985 Apr 18; 312(16):1011-5. PubMed ID: 3885033
    [Abstract] [Full Text] [Related]

  • 3. A prospective trial of D-penicillamine in primary biliary cirrhosis.
    Matloff DS, Alpert E, Resnick RH, Kaplan MM.
    N Engl J Med; 1982 Feb 11; 306(6):319-26. PubMed ID: 7033789
    [Abstract] [Full Text] [Related]

  • 4. Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis.
    Deering TB, Dickson ER, Fleming CR, Geall MG, McCall JT, Baggenstoss AH.
    Gastroenterology; 1977 Jun 11; 72(6):1208-12. PubMed ID: 870369
    [Abstract] [Full Text] [Related]

  • 5. A controlled trial of D-penicillamine therapy in primary biliary cirrhosis.
    Jain S, Scheuer PJ, Samourian S, McGee JO.
    Lancet; 1977 Apr 16; 1(8016):831-4. PubMed ID: 67338
    [Abstract] [Full Text] [Related]

  • 6. A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis.
    Bodenheimer HC, Schaffner F, Sternlieb I, Klion FM, Vernace S, Pezzullo J.
    Hepatology; 1985 Apr 16; 5(6):1139-42. PubMed ID: 3905561
    [Abstract] [Full Text] [Related]

  • 7. Copper stains and the syndrome of primary biliary cirrhosis. Evaluation of staining methods and their usefulness for diagnosis and trials of penicillamine treatment.
    Ludwig J, McDonald GS, Dickson ER, Elveback LR, McCall JT.
    Arch Pathol Lab Med; 1979 Aug 16; 103(9):467-70. PubMed ID: 88927
    [Abstract] [Full Text] [Related]

  • 8. Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.
    Neuberger J, Christensen E, Portmann B, Caballeria J, Rodes J, Ranek L, Tygstrup N, Williams R.
    Gut; 1985 Feb 16; 26(2):114-9. PubMed ID: 3881323
    [Abstract] [Full Text] [Related]

  • 9. The syndrome of primary biliary cirrhosis.
    Dickson ER.
    J Rheumatol Suppl; 1981 Feb 16; 7():121-3. PubMed ID: 6939874
    [Abstract] [Full Text] [Related]

  • 10. Autoimmune associations in primary biliary cirrhosis.
    Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER.
    Mayo Clin Proc; 1982 Jun 16; 57(6):365-70. PubMed ID: 6896227
    [Abstract] [Full Text] [Related]

  • 11. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis.
    Epstein O, De Villiers D, Jain S, Potter BJ, Thomas HC, Sherlock S.
    N Engl J Med; 1979 Feb 08; 300(6):274-8. PubMed ID: 759879
    [Abstract] [Full Text] [Related]

  • 12. Hepatic copper in primary biliary cirrhosis: biliary excretion and response to penicillamine treatment.
    Salaspuro MP, Pikkarainen P, Sipponen P, Vuori E, Miettinen TA.
    Gut; 1981 Nov 08; 22(11):901-6. PubMed ID: 7308845
    [Abstract] [Full Text] [Related]

  • 13. Systematic review and meta-analysis: D-Penicillamine vs. placebo/no intervention in patients with primary biliary cirrhosis--Cochrane Hepato-Biliary Group.
    Gong Y, Klingenberg SL, Gluud C.
    Aliment Pharmacol Ther; 2006 Dec 08; 24(11-12):1535-44. PubMed ID: 17206942
    [Abstract] [Full Text] [Related]

  • 14. Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis.
    Seehafer JR, Rogers RS, Fleming CR, Dickson ER.
    Arch Dermatol; 1981 Mar 08; 117(3):140-2. PubMed ID: 6452095
    [Abstract] [Full Text] [Related]

  • 15. Time course of histological progression in primary biliary cirrhosis.
    Locke GR, Therneau TM, Ludwig J, Dickson ER, Lindor KD.
    Hepatology; 1996 Jan 08; 23(1):52-6. PubMed ID: 8550048
    [Abstract] [Full Text] [Related]

  • 16. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F, Akarca US, Ersöz G, Karasu Z, Yüce G, Batur Y.
    Hepatogastroenterology; 2002 Jan 08; 49(47):1195-200. PubMed ID: 12239904
    [Abstract] [Full Text] [Related]

  • 17. D-penicillamine for primary biliary cirrhosis.
    Gong Y, Frederiksen SL, Gluud C.
    Cochrane Database Syst Rev; 2004 Oct 18; 2004(4):CD004789. PubMed ID: 15495127
    [Abstract] [Full Text] [Related]

  • 18. [Antibodies against D-penicillamine in primary biliary cirrhosis].
    Storch W.
    Immun Infekt; 1990 Feb 18; 18(1):22-3. PubMed ID: 2179124
    [Abstract] [Full Text] [Related]

  • 19. Hepatic copper accumulation in primary biliary cirrhosis.
    Benson GD.
    Yale J Biol Med; 1979 Feb 18; 52(1):83-8. PubMed ID: 452626
    [Abstract] [Full Text] [Related]

  • 20. Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis.
    Taal BG, Schalm SW, Ten Kate FW, Van Berge Henegouwen GP, Brandt KH.
    Liver; 1983 Dec 18; 3(6):345-52. PubMed ID: 6366419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.